Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL263699

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCNC(=NC1=NC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=N1)C3=O)NCC

Basic Information

ChEMBL ID CHEMBL263699
Phase Preclinical
Structure Type MOL
InChI Key JAZZEAWLYURRLN-JCHDHGHJSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

667.8
MW (Da)
2.58
ALogP
10
HBA
5
HBD
198.3
PSA (Ų)
0.13
QED
1
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C34H49N7O7
MW 667.81
Aromatic Rings 0
Heavy Atoms 48
NP-Likeness 1.75

Activity Summary

IC50 1 meas. best 6.68

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
SK-BR-3
CHEMBL613834
IC50 6.68 6.68 210.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
SK-BR-3 IC50 = 210.0 nM 6.68 Inhibition of oncogene product p185 erbB-2 from human breast cancer cells(SK-BR-... 7562911

Literature References

PubMed DOI Target Context # Activities
7562911 10.1021/jm00019a010 SK-BR-3 1

Data from ChEMBL 36 via Core Engine